Monica Morrow Selected Research

Unilateral Breast Neoplasms

11/2023	Examining Race and Patient-Reported Outcomes After Contralateral Prophylactic Mastectomy with Reconstruction.
5/2023	Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
1/2019	Patterns and Correlates of Knowledge, Communication, and Receipt of Breast Reconstruction in a Modern Population-Based Cohort of Patients with Breast Cancer.
1/2017	Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
10/2013	Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction.
6/2011	Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica Morrow Research Topics

Disease

220	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2002
157	Neoplasms (Cancer) 12/2023 - 09/2002
43	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2022 - 09/2002
21	Neoplasm Metastasis (Metastasis) 10/2023 - 12/2008
16	Pathologic Complete Response 12/2023 - 06/2005
10	Carcinoma (Carcinomatosis) 10/2021 - 02/2002
9	Triple Negative Breast Neoplasms 05/2024 - 10/2012
9	Inflammation (Inflammations) 10/2021 - 07/2011
8	Obesity 01/2023 - 07/2011
6	Unilateral Breast Neoplasms 11/2023 - 06/2011
6	Lymphadenopathy 10/2021 - 05/2010
6	Margins of Excision 11/2016 - 10/2002
5	Necrosis 12/2023 - 10/2011
5	Breast Carcinoma In Situ 10/2023 - 05/2004
5	Lobular Carcinoma 01/2023 - 06/2006
5	Pain (Aches) 10/2022 - 11/2020
5	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 08/2009
4	Extranodal Extension 05/2020 - 09/2014
4	Ductal Carcinoma 11/2015 - 02/2003
3	Lymphedema (Milroy Disease) 03/2024 - 12/2010
3	Hyperplasia 09/2005 - 05/2004
2	Calcinosis 01/2023 - 05/2015
2	Postoperative Pain 10/2022 - 03/2022
2	Breast Diseases (Breast Disease) 04/2022 - 02/2017
2	Contracture 01/2022 - 09/2020
2	Disease Progression 07/2021 - 06/2011
2	Residual Neoplasm 01/2021 - 02/2003
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2020 - 01/2014
2	Hypertrophy 01/2018 - 04/2017
2	Neoplasm Micrometastasis 12/2017 - 08/2017
2	Overweight 04/2012 - 07/2011
2	Carcinoma in Situ 01/2008 - 04/2005
1	Body Weight (Weight, Body) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023

Drug/Important Bio-Agent (IBA)

45	Estrogen ReceptorsIBA 05/2023 - 01/2008
27	Hormones (Hormone)IBA 12/2023 - 06/2003
18	Progesterone Receptors (Progesterone Receptor)IBA 12/2022 - 01/2008
10	human ERBB2 proteinIBA 01/2023 - 10/2010
10	Aromatase (CYP19)IBA 03/2021 - 07/2009
9	ErbB Receptors (EGF Receptor)IBA 12/2023 - 08/2015
9	Tamoxifen FDA LinkGeneric 01/2018 - 05/2003
8	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2008
7	Estrogens (Estrogen)FDA Link 01/2023 - 05/2015
6	Opioid Analgesics (Opioids)IBA 10/2022 - 11/2020
5	Eosine Yellowish-(YS) (Eosin)IBA 10/2016 - 07/2009
5	Hematoxylin (Haematoxylon)IBA 10/2016 - 07/2009
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2008
4	LeptinIBA 01/2023 - 01/2016
3	Insulin (Novolin)FDA Link 01/2023 - 01/2016
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2021 - 11/2020
3	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 07/2012
3	Epidermal Growth Factor (EGF)IBA 10/2019 - 11/2017
3	C-Reactive ProteinIBA 04/2017 - 01/2016
3	Trastuzumab (Herceptin)FDA Link 01/2017 - 12/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 06/2005
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 06/2005
3	Indicators and Reagents (Reagents)IBA 04/2015 - 10/2012
2	KetorolacIBA 10/2021 - 09/2021
2	Dihydrotachysterol (AT 10)IBA 12/2020 - 12/2016
2	PlasticsIBA 01/2020 - 05/2007
2	Dinoprostone (PGE2)FDA Link 01/2019 - 04/2012
2	LigandsIBA 01/2018 - 10/2013
2	Triglycerides (Triacylglycerol)IBA 04/2017 - 01/2016
2	EnzymesIBA 04/2017 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2016
2	IpilimumabIBA 12/2016 - 10/2016
2	CytokinesIBA 12/2016 - 11/2016
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2015 - 10/2014
2	Phenobarbital (Luminal)FDA Link 10/2010 - 10/2009
2	Coloring Agents (Dyes)IBA 12/2008 - 09/2005
1	ZincIBA 01/2023
1	CarbonatesIBA 01/2023
1	MineralsIBA 01/2023
1	ApatitesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	IronIBA 01/2023
1	AluminumIBA 01/2023
1	LipidsIBA 01/2023

Therapy/Procedure

92	Therapeutics 11/2023 - 02/2002
85	Mastectomy (Mammectomy) 02/2024 - 08/2003
85	Segmental Mastectomy (Lumpectomy) 10/2023 - 02/2002
57	Neoadjuvant Therapy 04/2024 - 02/2005
44	Radiotherapy 10/2023 - 09/2004
31	Drug Therapy (Chemotherapy) 05/2024 - 05/2003
24	Lymph Node Excision (Lymph Node Dissection) 04/2024 - 07/2009
17	Prophylactic Mastectomy 05/2023 - 10/2004
9	Aftercare (After-Treatment) 04/2021 - 09/2002
9	Mammaplasty (Breast Reconstruction) 01/2019 - 07/2006
6	Chemoprevention 07/2019 - 01/2002
5	Adjuvant Chemotherapy 01/2023 - 06/2005
5	Contraindications 09/2020 - 09/2002
4	Immunotherapy 05/2024 - 10/2016
4	Tissue Expansion Devices (Tissue Expander) 12/2023 - 05/2009
4	Breast Implants (Breast Implant) 01/2020 - 05/2009
3	Analgesia 10/2022 - 10/2021
3	Simple Mastectomy 10/2021 - 10/2002
2	Modified Radical Mastectomy (Mastectomy, Modified) 01/2023 - 05/2009
2	Cryosurgery 12/2016 - 10/2016
1	Treatment Delay 05/2024